+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Cephradine Market by Formulation (Capsules, Injectable, Oral Suspension), Application (Respiratory Tract Infections, Skin & Structure Infections, Urinary Tract Infections), Distribution Channel - Forecast 2024-2030- Product Image
Global Cephradine Market by Formulation (Capsules, Injectable, Oral Suspension), Application (Respiratory Tract Infections, Skin & Structure Infections, Urinary Tract Infections), Distribution Channel - Forecast 2024-2030- Product Image
Sale

Global Cephradine Market by Formulation (Capsules, Injectable, Oral Suspension), Application (Respiratory Tract Infections, Skin & Structure Infections, Urinary Tract Infections), Distribution Channel - Forecast 2024-2030

  • PDF Icon

    Report

  • 181 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 5968120
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Cephradine Market size was estimated at USD 441.57 million in 2023, USD 453.76 million in 2024, and is expected to grow at a CAGR of 2.91% to reach USD 540.13 million by 2030.

Cephradine is a type of antibiotic that belongs to the cephalosporin class, used in bacterial infections treatment by impeding the bacteria's ability to form cell walls, which results in bacterial death. The factors contributing to the increased use of Cephradine include its effectiveness in treating a range of bacterial infections including skin infections, urinary tract infections, and respiratory tract infections. Additionally, its relatively well-tolerated nature by patients compared to more potent antibiotics contributes to its popularity in clinical use.

However, potential allergic reactions in individuals sensitive to cephalosporins and their overuse lead to the development of antibiotic-resistant bacteria, a significant and growing public health issue. Nevertheless, formulation enhancements that reduce common side effects or improve the efficacy of the drug, thereby boosting its acceptability and usage, may increase its adoption. Research into combination therapies that could potentially mitigate resistance and increase effectiveness might also present new market opportunities.

Regional Insights

In the Americas, particularly the United States, the Cephradine market is influenced by stringent regulatory standards and a well-established healthcare infrastructure that ensures its reliable distribution and usage in clinical settings. There is a significant focus on combating antibiotic resistance, which affects how antibiotics such as cephradine are prescribed. In the EMEA region, market dynamics vary widely due to the diverse economic, healthcare, and regulatory environments. European countries often see a high adoption rate of new and effective treatments due to strong healthcare systems and active governmental healthcare policies.

However, in the Middle East and Africa, the market growth is constrained by less-developed healthcare systems and varying degrees of access to medical treatments, although there is growing awareness and some improvement in healthcare practices. The Asia Pacific region showcases a growing landscape for cephradine, driven by increasing healthcare expenditures and growing awareness of health issues. Countries including China and India, with their large populations and improving healthcare infrastructure, offer significant opportunities for the expansion of the Cephradine market.

Market Trends by Segment

  • Formulation: Suitability of injectable form of Cephradine in clinical settings for rapid response
  • Application: Effectiveness of cephradine respiratory tract infections due to its ability to withstand bacterial enzymes

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

Addressing Antimicrobial Resistance: FDA Approves New Antibiotic Ceftobiprole

In response to the escalating threat of antimicrobial resistance (AMR), the FDA recently approved a novel antibiotic, Zevtera (ceftobiprole medocaril sodium for injection), which enhances the arsenal against stubborn infections. Zevtera is sanctioned for treating adults with Staphylococcus aureus bloodstream infections, including right-sided infective endocarditis, severe bacterial skin infections, and bacterial pneumonia in both adults and older infants.

FDA Requests Additional Data for Venatorx and Melinta's Antibiotic NDA

Venatorx Pharmaceuticals and Melinta Therapeutics have received a Complete Response Letter from the U.S. Food and Drug Administration (FDA) concerning their New Drug Application for cefepime-taniborbactam, designed to treat complicated urinary tract infections in adults, including acute pyelonephritis. Both companies expressed their commitment to fulfilling the FDA's requests swiftly.

Key Company Profiles

The report delves into recent significant developments in the Cephradine Market, highlighting leading vendors and their innovative profiles. These include Bristol-Myers Squibb Company, Corden Pharma GmbH, E.R. Squibb & Sons, L.L.C., Fengchen Group Co.,Ltd, GlaxoSmithKline PLC, Hanmi Pharm.Co.,Ltd., Livzon Pharmaceutical Group Co., Lupin Limited, Qilu Pharmaceutical Co., Ltd., Sandoz Group AG, SimSon Pharma Limited, Taj Pharmaceuticals Limited, and Teva Pharmaceuticals.

This research report offers invaluable insights into various crucial aspects of the Cephradine Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of bacterial infections worldwide
5.1.1.2. Rising trend toward personalized medicine for the treatment of bacterial infections
5.1.2. Restraints
5.1.2.1. Concerns over potential adverse effects or side effects of cephradine
5.1.3. Opportunities
5.1.3.1. Innovations in drug delivery mechanisms to enhance the efficacy and convenience
5.1.3.2. Continued investments in research and development to discover new formulations
5.1.4. Challenges
5.1.4.1. Strict regulatory standards and compliance requirements across different regions
5.2. Market Segmentation Analysis
5.2.1. Formulation: Suitability of injectable form of Cephradine in clinical settings for rapid response
5.2.2. Application: Effectiveness of cephradine respiratory tract infections due to its ability to withstand bacterial enzymes
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Cephradine Market, by Formulation
6.1. Introduction
6.2. Capsules
6.3. Injectable
6.4. Oral Suspension
7. Cephradine Market, by Application
7.1. Introduction
7.2. Respiratory Tract Infections
7.3. Skin & Structure Infections
7.4. Urinary Tract Infections
8. Cephradine Market, by Distribution Channel
8.1. Introduction
8.2. Hospital Pharmacies
8.3. Online Pharmacies
8.4. Retail Pharmacies
9. Americas Cephradine Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Cephradine Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Cephradine Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Addressing Antimicrobial Resistance: FDA Approves New Antibiotic Ceftobiprole
12.3.2. FDA Requests Additional Data for Venatorx and Melinta's Antibiotic NDA
12.4. Strategy Analysis & Recommendation
13. Competitive Portfolio
13.1. Key Company Profiles
13.2. Key Product Portfolio
List of Figures
FIGURE 1. CEPHRADINE MARKET RESEARCH PROCESS
FIGURE 2. CEPHRADINE MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CEPHRADINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CEPHRADINE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL CEPHRADINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. CEPHRADINE MARKET DYNAMICS
FIGURE 7. GLOBAL CEPHRADINE MARKET SIZE, BY FORMULATION, 2023 VS 2030 (%)
FIGURE 8. GLOBAL CEPHRADINE MARKET SIZE, BY FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CEPHRADINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. GLOBAL CEPHRADINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 12. GLOBAL CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS CEPHRADINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS CEPHRADINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES CEPHRADINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES CEPHRADINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC CEPHRADINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC CEPHRADINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CEPHRADINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CEPHRADINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. CEPHRADINE MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. CEPHRADINE MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. CEPHRADINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CEPHRADINE MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL CEPHRADINE MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL CEPHRADINE MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL CEPHRADINE MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL CEPHRADINE MARKET SIZE, BY CAPSULES, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL CEPHRADINE MARKET SIZE, BY CAPSULES, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL CEPHRADINE MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL CEPHRADINE MARKET SIZE, BY INJECTABLE, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL CEPHRADINE MARKET SIZE, BY ORAL SUSPENSION, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL CEPHRADINE MARKET SIZE, BY ORAL SUSPENSION, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL CEPHRADINE MARKET SIZE, BY RESPIRATORY TRACT INFECTIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL CEPHRADINE MARKET SIZE, BY RESPIRATORY TRACT INFECTIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL CEPHRADINE MARKET SIZE, BY SKIN & STRUCTURE INFECTIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL CEPHRADINE MARKET SIZE, BY SKIN & STRUCTURE INFECTIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL CEPHRADINE MARKET SIZE, BY URINARY TRACT INFECTIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL CEPHRADINE MARKET SIZE, BY URINARY TRACT INFECTIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL CEPHRADINE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL CEPHRADINE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL CEPHRADINE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL CEPHRADINE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL CEPHRADINE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL CEPHRADINE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. AMERICAS CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 32. AMERICAS CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 33. AMERICAS CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 34. AMERICAS CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 35. AMERICAS CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 36. AMERICAS CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 37. AMERICAS CEPHRADINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 38. AMERICAS CEPHRADINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 39. ARGENTINA CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 40. ARGENTINA CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 41. ARGENTINA CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 42. ARGENTINA CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 43. ARGENTINA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 44. ARGENTINA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 45. BRAZIL CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 46. BRAZIL CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 47. BRAZIL CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 48. BRAZIL CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 49. BRAZIL CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 50. BRAZIL CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 51. CANADA CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 52. CANADA CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 53. CANADA CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 54. CANADA CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 55. CANADA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 56. CANADA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 57. MEXICO CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 58. MEXICO CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 59. MEXICO CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 60. MEXICO CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 61. MEXICO CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 62. MEXICO CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 63. UNITED STATES CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 64. UNITED STATES CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 65. UNITED STATES CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 66. UNITED STATES CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 67. UNITED STATES CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 68. UNITED STATES CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 69. UNITED STATES CEPHRADINE MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 70. UNITED STATES CEPHRADINE MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 72. ASIA-PACIFIC CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 73. ASIA-PACIFIC CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 74. ASIA-PACIFIC CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 75. ASIA-PACIFIC CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 76. ASIA-PACIFIC CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 77. ASIA-PACIFIC CEPHRADINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 78. ASIA-PACIFIC CEPHRADINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 79. AUSTRALIA CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 80. AUSTRALIA CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 81. AUSTRALIA CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 82. AUSTRALIA CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 83. AUSTRALIA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 84. AUSTRALIA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 85. CHINA CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 86. CHINA CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 87. CHINA CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 88. CHINA CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 89. CHINA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 90. CHINA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 91. INDIA CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 92. INDIA CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 93. INDIA CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 94. INDIA CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 95. INDIA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 96. INDIA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 97. INDONESIA CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 98. INDONESIA CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 99. INDONESIA CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 100. INDONESIA CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 101. INDONESIA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 102. INDONESIA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 103. JAPAN CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 104. JAPAN CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 105. JAPAN CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 106. JAPAN CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 107. JAPAN CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 108. JAPAN CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 109. MALAYSIA CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 110. MALAYSIA CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 111. MALAYSIA CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 112. MALAYSIA CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 113. MALAYSIA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 114. MALAYSIA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 115. PHILIPPINES CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 116. PHILIPPINES CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 117. PHILIPPINES CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 118. PHILIPPINES CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 119. PHILIPPINES CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 120. PHILIPPINES CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 121. SINGAPORE CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 122. SINGAPORE CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 123. SINGAPORE CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 124. SINGAPORE CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 125. SINGAPORE CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 126. SINGAPORE CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 127. SOUTH KOREA CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 128. SOUTH KOREA CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 129. SOUTH KOREA CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 130. SOUTH KOREA CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 131. SOUTH KOREA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 132. SOUTH KOREA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 133. TAIWAN CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 134. TAIWAN CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 135. TAIWAN CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 136. TAIWAN CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 137. TAIWAN CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 138. TAIWAN CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 139. THAILAND CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 140. THAILAND CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 141. THAILAND CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 142. THAILAND CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 143. THAILAND CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 144. THAILAND CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 145. VIETNAM CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 146. VIETNAM CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 147. VIETNAM CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 148. VIETNAM CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 149. VIETNAM CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 150. VIETNAM CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA CEPHRADINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA CEPHRADINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 159. DENMARK CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 160. DENMARK CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 161. DENMARK CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 162. DENMARK CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 163. DENMARK CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 164. DENMARK CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 165. EGYPT CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 166. EGYPT CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 167. EGYPT CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 168. EGYPT CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 169. EGYPT CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 170. EGYPT CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 171. FINLAND CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 172. FINLAND CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 173. FINLAND CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 174. FINLAND CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 175. FINLAND CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 176. FINLAND CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 177. FRANCE CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 178. FRANCE CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 179. FRANCE CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 180. FRANCE CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 181. FRANCE CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 182. FRANCE CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 183. GERMANY CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 184. GERMANY CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 185. GERMANY CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 186. GERMANY CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 187. GERMANY CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 188. GERMANY CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 189. ISRAEL CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 190. ISRAEL CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 191. ISRAEL CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 192. ISRAEL CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 193. ISRAEL CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 194. ISRAEL CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 195. ITALY CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 196. ITALY CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 197. ITALY CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 198. ITALY CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 199. ITALY CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 200. ITALY CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 201. NETHERLANDS CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 202. NETHERLANDS CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 203. NETHERLANDS CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 204. NETHERLANDS CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 205. NETHERLANDS CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 206. NETHERLANDS CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 207. NIGERIA CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 208. NIGERIA CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 209. NIGERIA CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 210. NIGERIA CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 211. NIGERIA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 212. NIGERIA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 213. NORWAY CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 214. NORWAY CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 215. NORWAY CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 216. NORWAY CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 217. NORWAY CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 218. NORWAY CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 219. POLAND CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 220. POLAND CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 221. POLAND CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 222. POLAND CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 223. POLAND CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 224. POLAND CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 225. QATAR CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 226. QATAR CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 227. QATAR CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 228. QATAR CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 229. QATAR CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 230. QATAR CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 231. RUSSIA CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 232. RUSSIA CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 233. RUSSIA CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 234. RUSSIA CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 235. RUSSIA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 236. RUSSIA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 238. SAUDI ARABIA CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 240. SAUDI ARABIA CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 242. SAUDI ARABIA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 244. SOUTH AFRICA CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 246. SOUTH AFRICA CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 248. SOUTH AFRICA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 249. SPAIN CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 250. SPAIN CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 251. SPAIN CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 252. SPAIN CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 253. SPAIN CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 254. SPAIN CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 255. SWEDEN CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 256. SWEDEN CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 257. SWEDEN CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 258. SWEDEN CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 259. SWEDEN CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 260. SWEDEN CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 261. SWITZERLAND CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 262. SWITZERLAND CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 263. SWITZERLAND CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 264. SWITZERLAND CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 265. SWITZERLAND CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 266. SWITZERLAND CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 267. TURKEY CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 268. TURKEY CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 269. TURKEY CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 270. TURKEY CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 271. TURKEY CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 272. TURKEY CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 278. UNITED ARAB EMIRATES CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 280. UNITED KINGDOM CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 282. UNITED KINGDOM CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 284. UNITED KINGDOM CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 285. CEPHRADINE MARKET SHARE, BY KEY PLAYER, 2023
TABLE 286. CEPHRADINE MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

  • Bristol-Myers Squibb Company
  • Corden Pharma GmbH
  • E.R. Squibb & Sons, L.L.C.
  • Fengchen Group Co.,Ltd
  • GlaxoSmithKline PLC
  • Hanmi Pharm.Co.,Ltd.
  • Livzon Pharmaceutical Group Co.
  • Lupin Limited
  • Qilu Pharmaceutical Co., Ltd.
  • Sandoz Group AG
  • SimSon Pharma Limited
  • Taj Pharmaceuticals Limited
  • Teva Pharmaceuticals

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages181
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 453.76 Million
Forecasted Market Value ( USD ) by 2030 $ 540.13 Million
Compound Annual Growth Rate2.9%
Regions CoveredGlobal
No. of Companies Mentioned13

Related Topics

Related Reports

Cephradine Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, and Product Type - Product Image

Cephradine Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, and Product Type

  • Report
  • 116 Pages
  • Global
From
Cephradine arginine (CAS 85760-50-5) Global Market Research Report 2024 - Product Image

Cephradine arginine (CAS 85760-50-5) Global Market Research Report 2024

  • Report
  • 50 Pages
  • Global
From
Cephalosporin Markets in China - Product Image

Cephalosporin Markets in China

  • Report
  • 270 Pages
  • China
From
Cephalosporin Industry Forecasts - China Focus - Product Image

Cephalosporin Industry Forecasts - China Focus

  • Report
  • 135 Pages
  • China
From
Global Cefaclor Market by Type (EP, USP), Spectrum Activity (Gram-Negative Bacteria, Gram-Positive Bacteria), Formulation, Application - Forecast 2024-2030 - Product Image

Global Cefaclor Market by Type (EP, USP), Spectrum Activity (Gram-Negative Bacteria, Gram-Positive Bacteria), Formulation, Application - Forecast 2024-2030

  • Report
  • 189 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.